Shanghai Runda Medical Technology Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Hui Liu
Chief executive officer
CN¥2.6m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 5yrs |
| CEO ownership | 5.3% |
| Management average tenure | 4.7yrs |
| Board average tenure | 4.4yrs |
Recent management updates
Recent updates
CEO
Hui Liu (50 yo)
5yrs
Tenure
CN¥2,599,100
Compensation
Mr. Hui Liu serves as the Vice Chairman and General Manager and Director at Shanghai Runda Medical Technology Co., Ltd and has been its Director since December 12, 2019. He served as Chairman of Shanghai R...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & Board Secretary | 5yrs | CN¥1.69m | no data | |
| GM & Vice Chairman | no data | CN¥2.60m | 5.26% CN¥ 583.0m | |
| Chief Financial Officer | 4.4yrs | CN¥995.20k | no data | |
| Deputy GM & Director | 5yrs | CN¥1.67m | 0.16% CN¥ 18.0m | |
| Deputy GM & Director | 5yrs | CN¥2.48m | 0.12% CN¥ 13.5m | |
| Accounting Supervisor | no data | no data | no data |
4.7yrs
Average Tenure
42yo
Average Age
Experienced Management: 603108's management team is considered experienced (4.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & Board Secretary | 5yrs | CN¥1.69m | no data | |
| GM & Vice Chairman | 5yrs | CN¥2.60m | 5.26% CN¥ 583.0m | |
| Deputy GM & Director | 1.9yrs | CN¥1.67m | 0.16% CN¥ 18.0m | |
| Deputy GM & Director | 5yrs | CN¥2.48m | 0.12% CN¥ 13.5m | |
| Independent Director | 5yrs | CN¥80.00k | no data | |
| Independent Director | 5yrs | CN¥80.00k | no data | |
| Supervisor | 4.4yrs | no data | no data | |
| Employee Supervisor | 4.4yrs | no data | no data | |
| Director | 1.9yrs | CN¥956.80k | no data | |
| Director | 1.9yrs | no data | no data | |
| Director | 1.9yrs | no data | no data | |
| Independent Director | 1.9yrs | CN¥73.30k | no data |
4.4yrs
Average Tenure
43.5yo
Average Age
Experienced Board: 603108's board of directors are considered experienced (4.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 11:35 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shanghai Runda Medical Technology Co., Ltd. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jin Zhang | China International Capital Corporation Limited |
| Xiao Wei Lin | Everbright Securities Co. Ltd. |
| Lin Yang | Haitong International Research Limited |